Cargando...

Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals

Robust manufacturing processes resulting in consistent glycosylation are critical for the efficacy and safety of biopharmaceuticals. Information on glycosylation can be obtained by conventional bottom–up methods but is often limited to the glycan or glycopeptide level. Here, we apply high-resolution...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Commun
Main Authors: Wohlschlager, Therese, Scheffler, Kai, Forstenlehner, Ines C., Skala, Wolfgang, Senn, Stefan, Damoc, Eugen, Holzmann, Johann, Huber, Christian G.
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group UK 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928108/
https://ncbi.nlm.nih.gov/pubmed/29712889
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-04061-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!